Explore

Supreme Court Maintains Telehealth Access for Abortion Pill Amid Legal Dispute

Supreme Court Maintains Telehealth Access for Abortion Pill Amid Legal Dispute

The Supreme Court has decided to keep the abortion pill mifepristone available via telehealth, maintaining the status quo as a legal challenge from Louisiana against the FDA proceeds. The decision blocks a lower court ruling that would have banned mailing the pill nationwide. Justices Samuel Alito and Clarence Thomas dissented, criticizing the decision as undermining state authority over abortion regulations. The ruling allows continued access to medication abortion, which has become increasingly common since the overturning of Roe v. Wade.

Supreme Court preserves access to widely used abortion pill, while lawsuit plays out

Supreme Court preserves access to widely used abortion pill, while lawsuit plays out

The Supreme Court has preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues

Explainer-US Supreme Court ruling preserves abortion pill access for now as other challenges loom

Explainer-US Supreme Court ruling preserves abortion pill access for now as other challenges loom

By Daniel Wiessner May 14 (Reuters) - The U.S. Supreme Court has for now refused to block a U.S.

Supreme Court Upholds Mail-Order Abortion Pills, Impacting Nationwide Access

Supreme Court Upholds Mail-Order Abortion Pills, Impacting Nationwide Access

The Supreme Court has upheld the availability of the abortion pill mifepristone by mail, rejecting a challenge from anti-abortion groups. The decision, made with a 7-2 vote, allows the continued distribution of mifepristone through mail following an online consultation with a doctor. This ruling overturns a previous decision by the 5th Circuit Court of Appeals, which had sought to ban the mail distribution of the medication. Justices Clarence Thomas and Samuel Alito dissented, expressing concerns about undermining state rights to regulate abortions as per the Dobbs v. Jackson Women’s Health Organization decision. The case will return to the 5th Circuit for further review, but for now, the FDA's regulations on remote dispensation via telehealth remain in place.

US Supreme Court lets abortion pill mail delivery continue

US Supreme Court lets abortion pill mail delivery continue

By Andrew Chung May 14 (Reuters) - The U.S. Supreme Court on Thursday allowed the abortion pill to be prescribed through telemedicine and dispensed by mail, restoring for now a 2023 federal rule challenged by Republican-governed Louisiana that had made access to the medication easier.

Supreme Court Allows Continued Telehealth Access to Abortion Pill Amid Legal Battle

Supreme Court Allows Continued Telehealth Access to Abortion Pill Amid Legal Battle

The Supreme Court has allowed the continued use of telehealth for accessing the abortion pill mifepristone, maintaining the status quo while a legal challenge from Louisiana proceeds. The court's decision temporarily halts a ruling by the 5th Circuit Court of Appeals that required in-person visits for obtaining the drug. Justices Thomas and Alito dissented, arguing that the decision undermines the court's previous ruling overturning Roe v. Wade. The case will now return to the appeals court for further consideration.

US Supreme Court Temporarily Restores Mail Access to Mifepristone Amid Legal Challenges

US Supreme Court Temporarily Restores Mail Access to Mifepristone Amid Legal Challenges

The U.S. Supreme Court has issued an administrative stay that temporarily restores mail and telemedicine access to mifepristone, a drug used in combination with misoprostol to terminate early pregnancies. This decision comes after the Fifth Circuit Court of Appeals imposed restrictions on the mail-order distribution of mifepristone nationwide. The legal battle began when Louisiana challenged the FDA's 2023 modification of the Risk Evaluation and Mitigation Strategies (REMS) for mifepristone, which had removed the in-person dispensing requirement. The Fifth Circuit's ruling temporarily reinstated these requirements, citing potential harm to Louisiana's ability to regulate abortions. The Supreme Court's stay allows the continued use of telemedicine and mail distribution of mifepristone until May 14, pending further review.

Supreme Court temporarily extends women's access to a widely used abortion pill

Supreme Court temporarily extends women's access to a widely used abortion pill

The Supreme Court is leaving women’s access to a widely used abortion pill untouched until at least Thursday, while the justices consider whether to allow restrictions on the drug, mifepristone, to take effect

US Supreme Court Temporarily Extends Mail-Order Access to Abortion Pill Mifepristone

US Supreme Court Temporarily Extends Mail-Order Access to Abortion Pill Mifepristone

The U.S. Supreme Court has temporarily extended access to mail-order mifepristone, an abortion medication, following a legal challenge from Louisiana. Justice Samuel Alito granted a temporary stay on a decision by the 5th U.S. Circuit Court of Appeals that banned the drug's mail distribution. The case, Louisiana v. FDA, argues that the FDA's telehealth policy for mifepristone violates state abortion bans. The Supreme Court's decision allows continued access to the drug while the court considers its next steps, highlighting the ongoing legal battles over reproductive rights and federal versus state regulatory authority.

Supreme Court Temporarily Extends Access to Abortion Pill Mifepristone Amid Legal Dispute

Supreme Court Temporarily Extends Access to Abortion Pill Mifepristone Amid Legal Dispute

The Supreme Court has temporarily extended access to the abortion pill mifepristone, allowing it to remain available through pharmacies and mail order until at least Thursday. This decision comes as the court deliberates on a ruling from the 5th Circuit Court of Appeals, which sought to reinstate pre-pandemic restrictions requiring in-person prescriptions. The case originated from a lawsuit filed by Louisiana, challenging the FDA's rules on mifepristone, arguing that telemedicine access undermines the state's abortion ban. The FDA had previously eased restrictions on the drug, which is used in combination with misoprostol for medication abortions, accounting for nearly two-thirds of all abortions in the U.S. in 2023. The Supreme Court's decision to extend access comes amidst ongoing debates and legal challenges surrounding abortion rights following the overturning of Roe v. Wade.

Justice Alito Extends Order Allowing Mail Distribution of Abortion Pill

Justice Alito Extends Order Allowing Mail Distribution of Abortion Pill

Supreme Court Justice Samuel A. Alito Jr. has extended a temporary order permitting the mail distribution of mifepristone, a widely used abortion pill, as the court deliberates on a broader ruling. This extension maintains the status quo while the justices consider whether to uphold a decision by the 5th Circuit Court of Appeals, which reinstated a requirement for in-person pickup of the pill. The case stems from a lawsuit by Louisiana against the FDA, challenging the Biden administration's rules that allow mail distribution of the drug, arguing it conflicts with the state's abortion restrictions.

Supreme Court Extends Access to Mifepristone Amid Ongoing Deliberations

Supreme Court Extends Access to Mifepristone Amid Ongoing Deliberations

The Supreme Court has extended a temporary order allowing continued access to the abortion pill mifepristone through telehealth visits, as it deliberates over an emergency appeal. Justice Samuel Alito issued the extension, which maintains the status quo while the court considers the case. The decision follows a 5th Circuit Court ruling that required in-person visits for obtaining the drug, a move that was challenged by the drug's manufacturer and other stakeholders. The case is significant as it addresses access to abortion medication in the wake of the Supreme Court's decision to overturn Roe v. Wade.